Your cart is empty.
Männedorf, Switzerland, May 24, 2011 – Tecan has recently updated its Infinite M1000 high-end multimode microplate reader with new features designed to offer the same top class performance for an even wider range of applications. First launched in 2008, the Infinite M1000 uses Tecan’s premium Quad4 Monochromators™ technology to offer exceptional speed, sensitivity and flexibility for academic, biotechnology and pharmaceutical research applications.
Already highly acclaimed for its scanning capabilities, the Infinite M1000 now offers luminescence scanning to complement its existing 3D and ultra fast absorbance and fluorescence scanning capabilities. Luciferase reporter mechanisms have become commonplace across a broad range of disciplines, making development of recombinant luciferases and novel substrates an important area of research. This new feature allows the emission spectra of stable luminescent signals to be recorded at 1 nm resolution using the instrument’s emission monochromators, making the Infinite M1000 an ideal platform for luminescence-based assay development.
The format flexibility of the Infinite M1000 has also been expanded, allowing Tecan’s patent pending NanoQuant Plate™ for very low volume absorbance measurements to be used alongside virtually all 6- to 1,536-well plate formats. Other new features include double orbital shaking for more efficient reagent mixing, an Optimal Read (OR) function for reliable cell-based measurements, and a completely new injector module offering precisely controlled pipetting for triggering fast kinetic reactions and bulk dispensing. The modular, upgradeable nature of Infinite series readers means that current Infinite M1000 customers can also benefit from these latest developments, as well as the soon to be launched AlphaScreen® option, making the Infinite M1000 a truly flexible solution to meet your changing laboratory needs.
For more information please contact
Tecan Trading AG
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2010, Tecan generated sales of CHF 371 million (USD 356 million; EUR 269 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN: 1210019).